HMOX1 and chronic kidney disease: Immunoblotting analysis showed that the expression of Nrf2 and HO-1 proteins was reduced in the CKD group, along with increased levels of Keap1, compared to those in the Sham group, which was attenuated by losartan treatment (Figure 6D).